3D Global Biotech Inc.(TW:6808)
NT$26.10+0.10 (+0.38%)
TW:6808
3D Global Biotech Inc. Revenue
NT$26.10
At close:+0.10 (+0.38%)
3D Global Biotech Inc. (6808) Revenue
3D Global Biotech Inc. Revenue
3D Global Biotech Inc. had a revenue of 55.30M in the quarter ending Jun 30, 2026, with -46.77%. This bring the company's revenue in the last twelve months to 159.19M, Decreased 23.00%. In the fiscal year ending Dec 31, 2025, 3D Global Biotech Inc. had annual revenue of 206.74M with -22.19% growth.
- Revenue (ttm)
- 159.19M
- Revenue Growth
- -51.00%
- P/S Ratio
- 9.66
- Revenue/Employee
- TWD 4,807,791
- Employees
- 43
- Market Cap
- TWD 2.00B
Revenue Chart
3D Global Biotech Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 206.74M | -58.95M | -22.19% |
| Dec 31, 2024 | 265.69M | 245.05M | 1187.68% |
| Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
| Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
| Dec 31, 2021 | 11.07M | -2.19M | -16.48% |
| Dec 31, 2020 | 13.26M | -4.92M | -27.05% |
| Dec 31, 2019 | 18.18M | 6.33M | 53.37% |
| Dec 31, 2018 | 11.85M | 2.54M | 27.30% |
| Dec 31, 2017 | 9.31M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.